MetaRing quickly identifies breast cancer drug sensitivity

Recently, a research team led by Prof. Wang Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has developed a programmable plasmonic ring biosensor, MetaRing, capable of rapidly and accurately identifying paclitaxel sensitivity in breast cancer patients. The study is published in Biosensors and Bioelectronics.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup